Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085))

Kanchana Subramani; Hsuan Shun Huang; Pao Chu Chen; Dah Ching Ding; Tang Yuan Chu

doi:10.1016/j.neo.2025.101183

Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085))

Kanchana Subramani, Hsuan Shun Huang, Pao Chu Chen, Dah Ching Ding, Tang Yuan Chu

婦產學科

研究成果: 期刊稿件 › 評論/辯論

摘要

The authors regret to inform that on the “Clinical specimen” section in Method, the sentence “Approval for the collection of clinical specimens was obtained from the Institutional Review Board of Tzu Chi General Hospital, Hualien, Taiwan (TCGH-IRB #93-025).” should have “(TCGH-IRB #93-025)” changed to “(IRB111-038-A)”. The authors would like to apologise for any inconvenience caused.

原文	英語
文章編號	101183
期刊	Neoplasia (United States)
卷	66
DOIs	https://doi.org/10.1016/j.neo.2025.101183
出版狀態	Published - 8月 2025

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1016/j.neo.2025.101183

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085))」主題。共同形成了獨特的指紋。

引用此

Subramani, K., Huang, H. S., Chen, P. C., Ding, D. C., & Chu, T. Y. (2025). Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085)). Neoplasia (United States), 66, 文章 101183. https://doi.org/10.1016/j.neo.2025.101183

@article{0cc8bf097dfa4f6ca3fd8ad5539574d0,

title = "Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085))",

abstract = "The authors regret to inform that on the “Clinical specimen” section in Method, the sentence “Approval for the collection of clinical specimens was obtained from the Institutional Review Board of Tzu Chi General Hospital, Hualien, Taiwan (TCGH-IRB \#93-025).” should have “(TCGH-IRB \#93-025)” changed to “(IRB111-038-A)”. The authors would like to apologise for any inconvenience caused.",

author = "Kanchana Subramani and Huang, \{Hsuan Shun\} and Chen, \{Pao Chu\} and Ding, \{Dah Ching\} and Chu, \{Tang Yuan\}",

note = "Publisher Copyright: {\textcopyright} 2025 The Authors",

year = "2025",

month = aug,

doi = "10.1016/j.neo.2025.101183",

language = "英语",

volume = "66",

journal = "Neoplasia (United States)",

issn = "1522-8002",

publisher = "Elsevier Inc.",

}

Subramani, K, Huang, HS, Chen, PC, Ding, DC & Chu, TY 2025, 'Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085))', Neoplasia (United States), 卷 66, 101183. https://doi.org/10.1016/j.neo.2025.101183

Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085)). / Subramani, Kanchana; Huang, Hsuan Shun; Chen, Pao Chu 等.
於: Neoplasia (United States), 卷 66, 101183, 08.2025.

研究成果: 期刊稿件 › 評論/辯論

TY - JOUR

T1 - Corrigendum to “Ovulation sources ROS to confer mutagenic activities on the TP53 gene in the fallopian tube epithelium” [Neoplasia 59 (2025 Dec 4) 101085] (Neoplasia (2025) 59, (S147655862400126X), (10.1016/j.neo.2024.101085))

AU - Subramani, Kanchana

AU - Huang, Hsuan Shun

AU - Chen, Pao Chu

AU - Ding, Dah Ching

AU - Chu, Tang Yuan

PY - 2025/8

Y1 - 2025/8

N2 - The authors regret to inform that on the “Clinical specimen” section in Method, the sentence “Approval for the collection of clinical specimens was obtained from the Institutional Review Board of Tzu Chi General Hospital, Hualien, Taiwan (TCGH-IRB #93-025).” should have “(TCGH-IRB #93-025)” changed to “(IRB111-038-A)”. The authors would like to apologise for any inconvenience caused.

AB - The authors regret to inform that on the “Clinical specimen” section in Method, the sentence “Approval for the collection of clinical specimens was obtained from the Institutional Review Board of Tzu Chi General Hospital, Hualien, Taiwan (TCGH-IRB #93-025).” should have “(TCGH-IRB #93-025)” changed to “(IRB111-038-A)”. The authors would like to apologise for any inconvenience caused.

UR - https://www.scopus.com/pages/publications/105006711205

U2 - 10.1016/j.neo.2025.101183

DO - 10.1016/j.neo.2025.101183

M3 - 评论/辩论

C2 - 40446668

AN - SCOPUS:105006711205

SN - 1522-8002

VL - 66

JO - Neoplasia (United States)

JF - Neoplasia (United States)

M1 - 101183

ER -